vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $22.2M, roughly 1.4× GREENE COUNTY BANCORP INC). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -32.1%, a 78.4% gap on every dollar of revenue. On growth, GREENE COUNTY BANCORP INC posted the faster year-over-year revenue change (23.8% vs -4.5%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $25.0K). Over the past eight quarters, GREENE COUNTY BANCORP INC's revenue compounded faster (18.9% CAGR vs -0.1%).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
GCBC vs LFCR — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $31.1M |
| Net Profit | $10.3M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | 52.0% | -9.9% |
| Net Margin | 46.3% | -32.1% |
| Revenue YoY | 23.8% | -4.5% |
| Net Profit YoY | 37.4% | -52.0% |
| EPS (diluted) | $0.60 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.2M | — | ||
| Q3 25 | $21.5M | $31.1M | ||
| Q2 25 | $20.5M | — | ||
| Q1 25 | $20.1M | $35.2M | ||
| Q4 24 | $17.9M | $32.6M | ||
| Q3 24 | $16.9M | $24.7M | ||
| Q2 24 | $16.6M | — | ||
| Q1 24 | $15.7M | $35.7M |
| Q4 25 | $10.3M | — | ||
| Q3 25 | $8.9M | $-10.0M | ||
| Q2 25 | $9.3M | — | ||
| Q1 25 | $8.1M | $-14.8M | ||
| Q4 24 | $7.5M | $-6.6M | ||
| Q3 24 | $6.3M | $-16.2M | ||
| Q2 24 | $6.7M | — | ||
| Q1 24 | $5.9M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | 52.0% | — | ||
| Q3 25 | 47.4% | -9.9% | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | 44.6% | -25.7% | ||
| Q4 24 | 45.0% | -6.0% | ||
| Q3 24 | 39.6% | -46.9% | ||
| Q2 24 | 41.2% | — | ||
| Q1 24 | 39.4% | -2.5% |
| Q4 25 | 46.3% | — | ||
| Q3 25 | 41.2% | -32.1% | ||
| Q2 25 | 45.6% | — | ||
| Q1 25 | 40.1% | -42.0% | ||
| Q4 24 | 41.7% | -20.2% | ||
| Q3 24 | 37.1% | -65.7% | ||
| Q2 24 | 40.6% | — | ||
| Q1 24 | 37.3% | 43.8% |
| Q4 25 | $0.60 | — | ||
| Q3 25 | $0.52 | $-0.29 | ||
| Q2 25 | $0.55 | — | ||
| Q1 25 | $0.47 | $-0.47 | ||
| Q4 24 | $0.44 | $-0.25 | ||
| Q3 24 | $0.37 | $-0.53 | ||
| Q2 24 | $0.39 | — | ||
| Q1 24 | $0.34 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $258.3M | $-10.5M |
| Total Assets | $3.1B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | $155.5M | $5.4M | ||
| Q4 24 | $166.4M | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | $190.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $258.3M | — | ||
| Q3 25 | $248.2M | $-10.5M | ||
| Q2 25 | $238.8M | — | ||
| Q1 25 | $229.0M | $2.2M | ||
| Q4 24 | $218.4M | $15.4M | ||
| Q3 24 | $216.3M | $-3.9M | ||
| Q2 24 | $206.0M | — | ||
| Q1 24 | $199.2M | $17.7M |
| Q4 25 | $3.1B | — | ||
| Q3 25 | $3.1B | $235.2M | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.0B | $237.7M | ||
| Q4 24 | $3.0B | $255.4M | ||
| Q3 24 | $2.9B | $246.8M | ||
| Q2 24 | $2.8B | — | ||
| Q1 24 | $2.9B | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $1.8M |
| Free Cash FlowOCF − Capex | $6.2M | $25.0K |
| FCF MarginFCF / Revenue | 28.0% | 0.1% |
| Capex IntensityCapex / Revenue | 0.9% | 5.6% |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | — | ||
| Q3 25 | $7.0M | $1.8M | ||
| Q2 25 | $28.0M | — | ||
| Q1 25 | $7.3M | $1.2M | ||
| Q4 24 | $5.3M | $-6.1M | ||
| Q3 24 | $2.1M | $-613.0K | ||
| Q2 24 | $24.9M | — | ||
| Q1 24 | $5.6M | $-1.4M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.5M | $25.0K | ||
| Q2 25 | $27.3M | — | ||
| Q1 25 | $7.3M | $-4.3M | ||
| Q4 24 | $5.1M | $-8.6M | ||
| Q3 24 | $2.0M | $-4.0M | ||
| Q2 24 | $23.4M | — | ||
| Q1 24 | $4.9M | $-7.8M |
| Q4 25 | 28.0% | — | ||
| Q3 25 | 30.4% | 0.1% | ||
| Q2 25 | 133.3% | — | ||
| Q1 25 | 36.1% | -12.1% | ||
| Q4 24 | 28.6% | -26.3% | ||
| Q3 24 | 11.8% | -16.3% | ||
| Q2 24 | 141.2% | — | ||
| Q1 24 | 31.3% | -21.8% |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.9% | 5.6% | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 0.3% | 15.5% | ||
| Q4 24 | 1.0% | 7.5% | ||
| Q3 24 | 0.9% | 13.9% | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 4.2% | 17.8% |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 3.70× | — | ||
| Q1 24 | 0.95× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GCBC
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
